Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "CIDS"

38 News Found

CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance
News | August 19, 2024

CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance

The emergence of new infections in India is a growing concern


Remedium unveils Rights Issue post Rs. 182.7 crore UK deal to drive global expansion
News | April 24, 2025

Remedium unveils Rights Issue post Rs. 182.7 crore UK deal to drive global expansion

The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience


Wacker collaborates with RNAV8 Bio to enhance mRNA therapeutics development
Biotech | April 04, 2025

Wacker collaborates with RNAV8 Bio to enhance mRNA therapeutics development

This collaboration positions WACKER and RNAV8 as premium mRNA service providers


Innovaoleo launches Omega 3 Star for food, nutraceutical and pet nutrition
News | March 27, 2025

Innovaoleo launches Omega 3 Star for food, nutraceutical and pet nutrition

Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health


atulya launches winter essential kit for hair and skin care
Healthcare | January 16, 2025

atulya launches winter essential kit for hair and skin care

atulya keratin & wheat protein shampoo has force of natural ingredients like extract of wheat, fenugreek, reetha & almond oil


Evonik partners with South Korean ST Pharm to increase its offerings for RNA and nucleic acid delivery
News | January 09, 2025

Evonik partners with South Korean ST Pharm to increase its offerings for RNA and nucleic acid delivery

Increases speed to market for drug developers working on nucleic acid therapeutics


Akums launches dual action heartburn relief chewable tablet
News | October 12, 2024

Akums launches dual action heartburn relief chewable tablet

This product is categorized as antacids, antiflatulents and anti-Ulcerants


Evonik unveils latest global trial results MetAMINO
Diagnostic Center | April 04, 2024

Evonik unveils latest global trial results MetAMINO

Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine


Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery
News | February 18, 2024

Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery

Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery